5 completed. 5 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 5 |
| Phase 2 | 2 | Completed 2 |
Follow Otitis: new trials by email Literature Review of Otitis trials Research Report on Otitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Safety and Reduction of Ear Pain in Adults With Acute Otitis Media and Reduction of Ear Pain in Adults With Acute Otitis Media Drug: OP0201 20mg, Drug: Placebo 0mg - Acute Otitis Media | Phase 1 | Completed | Novus Therapeutics, Inc | 24 | 2019-01-07 | 2019-12-05 |
| Trans-Middle-Ear Mucosal Gas Exchange Project 1, Specific Aim 1 6%CO2, 25%O2, balance N2, 6% CO2, 0%O2, balance N2, 20%CO2, 6%O2, balance N2 - Middle Ear Gas Exchange | Phase 1 | Completed | Cuneyt M. Alper | 16 | 2014-05-13 | 2019-02-19 |
| Safety and Efficacy Study of Foam Otic Cipro Compared to a Standard Solution ( Ciloxan - Alcon Labs ) to Treat Acute Otitis Externa 0.3% Ciprofloxacin Ear Drops, 0.3% Ciprofloxacin Foam Otic Cipro - Otitis Externa, Otorhinolaryngologic Diseases | Phase 1 / Phase 2 | Completed | Otic Pharma | 100 | 2009-05-01 | 2009-12-24 |
| Maternal Immunization To Prevent Infant Otitis Media PNCRM9, Placebo comparator - Otitis Media | Phase 1 / Phase 2 | Completed | National Institute on Deafness and Other Communication Disorders (NIDCD) | 153 | 2000-10-01 | 2008-02-18 |
| Vaccination for Middle Ear Infection Nontypeable Haemophilus influenzae - Otitis Media | Phase 1 | Completed | National Institute on Deafness and Other Communication Disorders (NIDCD) | 40 | 1997-05-01 | 2008-03-04 |
Otitis Media (3) · Ear Diseases (1) · Earache (1) · Otitis Externa (1) · Otorhinolaryngologic Diseases (1) · Tetanus (1)
Ear Diseases (4) · Otorhinolaryngologic Diseases (4) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Clostridium Infections (1) · Gram-Positive Bacterial Infections (1) · Infections (1) · Neurologic Manifestations (1) · Pain (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Ciprofloxacin (1) · ompP2 protein, Haemophilus influenzae (1)
National Institute on Deafness and Other Communication Disorders (NIDCD) (2) · Cuneyt M. Alper (1) · Novus Therapeutics, Inc (1) · Otic Pharma (1)
United States (4) · Israel (1)
Cuneyt M Alper, MD (1) · Patricia Ferrieri (1) · Yehudah Roth, MD (1)
P50DC007667 (1)